ABPI’s Barker to step down
pharmafile | October 11, 2010 | Appointment | Sales and Marketing | ABPI, appointment, sales and marketing
ABPI director general Dr Richard Barker is to step down in 2011 after six years at the helm of the UK industry association.
The search for his successor will begin immediately, with the aim of making an appointment in Spring 2011. This would give Barker’s replacement a full year to work with current ABPI president Simon Jose before the next change in president.
Richard Barker said: “My time at the ABPI has been both challenging and fulfilling and I have been proud to represent this vital industry. It is both an engine of growth to support economic recovery and a continuing source of new medicines and vaccines to help the NHS deliver improved health.
“With the UK environment going through further rapid and dynamic evolution, next year will be a good time to hand over the reins to a new leader. I look forward to pursuing new opportunities outside the Association in the future, principally in healthcare.”
Following a handover to his successor in May 2011, Richard will act as a senior advisor to the Association for up to 12 months.
Simon Jose, president of the ABPI, said: “Richard has been a very visible champion for the ABPI over the past six years, engaging in both private and public discussions about a wide range of issues – from the importance of retaining clinical research in the UK, to mitigating the risk of medicines supply shortages – which are key not only to the industry, but to patients and the NHS.
“Under his leadership, the industry has worked increasingly closely and constructively with the UK Government and he played a leading role in establishing the Office for Life Sciences, and from it the launch of the UK’s Life Sciences Supercluster and personalised medicine initiatives.”
Related Content
David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.
The November 2020 issue of Pharmafocus is available to read free online now!
The latest monthly edition of Pharmafocus is available to read for free online now!
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …
